Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3.05

Margin Of Safety %

-12

Put/Call OI Ratio

0.6

EPS Next Q Diff

-0.81

EPS Last/This Y

7.14

EPS This/Next Y

5.65

Price

397.42

Target Price

503.54

Analyst Recom

1.81

Performance Q

-13.79

Relative Volume

1.48

Beta

0.31

Ticker: ALNY




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13ALNY453.940.670.4436040
2025-11-14ALNY448.950.681.3636123
2025-11-17ALNY460.570.681.3136276
2025-11-18ALNY462.190.681.8136271
2025-11-19ALNY460.720.690.2036422
2025-11-20ALNY445.660.690.7836442
2025-11-21ALNY436.270.681.0436318
2025-11-24ALNY434.330.601.6728193
2025-11-25ALNY429.760.610.5828900
2025-11-26ALNY445.40.600.6029241
2025-12-01ALNY454.610.601.0029393
2025-12-02ALNY465.10.610.5229679
2025-12-03ALNY473.560.610.5029928
2025-12-04ALNY465.480.610.1431110
2025-12-05ALNY458.080.590.6932049
2025-12-08ALNY429.850.590.3133090
2025-12-09ALNY415.190.600.2133021
2025-12-10ALNY405.460.610.3632728
2025-12-11ALNY412.870.610.4933167
2025-12-12ALNY398.550.600.8633277
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-13ALNY453.782574.8681.14.96
2025-11-14ALNY449.082574.8670.24.96
2025-11-17ALNY460.572574.8700.24.96
2025-11-18ALNY462.282574.8682.34.96
2025-11-19ALNY460.762574.8676.44.96
2025-11-20ALNY446.042787.9652.74.96
2025-11-21ALNY436.232787.9661.44.96
2025-11-24ALNY434.412787.9675.44.96
2025-11-25ALNY429.802787.9670.74.96
2025-11-26ALNY445.082787.9708.74.96
2025-12-01ALNY454.642787.9685.44.96
2025-12-02ALNY464.932787.9698.14.96
2025-12-03ALNY473.292787.9694.14.96
2025-12-04ALNY465.482787.9665.54.96
2025-12-05ALNY458.122787.9666.34.96
2025-12-08ALNY430.022787.9- 4.96
2025-12-09ALNY415.212787.9650.64.96
2025-12-10ALNY415.212787.9657.34.96
2025-12-11ALNY412.632787.9696.54.96
2025-12-12ALNY397.422787.9648.54.96
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-13ALNY-2.833.212.98
2025-11-14ALNY-3.263.212.91
2025-11-17ALNY-7.094.922.91
2025-11-18ALNY-7.094.922.91
2025-11-19ALNY-7.514.922.91
2025-11-20ALNY-7.124.922.91
2025-11-21ALNY-7.124.922.91
2025-11-24ALNY-7.122.092.90
2025-11-25ALNY-7.452.092.90
2025-11-26ALNY-7.452.093.30
2025-12-01ALNY-7.452.113.30
2025-12-02ALNY-7.452.113.30
2025-12-03ALNY-7.452.113.30
2025-12-04ALNY-5.572.113.30
2025-12-05ALNY-5.572.113.30
2025-12-08ALNY-5.632.113.30
2025-12-09ALNY-5.632.113.30
2025-12-10ALNY-5.632.113.05
2025-12-11ALNY-5.632.113.05
2025-12-12ALNY-5.632.113.05
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ALNY" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS

2.9

Avg. EPS Est. Current Quarter

1.73

Avg. EPS Est. Next Quarter

2.09

Insider Transactions

-5.63

Institutional Transactions

2.11

Beta

0.31

Average Sales Estimate Current Quarter

1171

Average Sales Estimate Next Quarter

1223

Fair Value

351.29

Quality Score

73

Growth Score

65

Sentiment Score

11

Actual DrawDown %

19.8

Max Drawdown 5-Year %

-42.5

Target Price

503.54

P/E

1653.7

Forward P/E

52.82

PEG

P/S

16.36

P/B

224.01

P/Free Cash Flow

237.27

EPS

0.24

Average EPS Est. Cur. Y​

4.96

EPS Next Y. (Est.)

10.61

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.36

Relative Volume

1.48

Return on Equity vs Sector %

-8.3

Return on Equity vs Industry %

6.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

648.5
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ALNY” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALNY” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALNY” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALNY” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALNY” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALNY” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ALNY” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Alnylam Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 2230
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
stock quote shares ALNY – Alnylam Pharmaceuticals, Inc. Stock Price stock today
news today ALNY – Alnylam Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALNY – Alnylam Pharmaceuticals, Inc. yahoo finance google finance
stock history ALNY – Alnylam Pharmaceuticals, Inc. invest stock market
stock prices ALNY premarket after hours
ticker ALNY fair value insiders trading